| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.6 |